Back
Rocket Pharmaceuticals Vs. Alnylam Pharmaceuticals Industry Stock Comparison
Buy
51
RCKT
Rocket Pharmaceuticals
Last Price:
20.67
Seasonality Move:
12.68%
Buy
61
ALNY
Alnylam Pharmaceuticals
Last Price:
243.28
Seasonality Move:
15.98%
Buy
51
Rocket Pharmaceuticals (RCKT)
is a Buy
Is Rocket Pharmaceuticals a Buy, Sell or Hold?
- The current Rocket Pharmaceuticals [RCKT] share price is $20.66. The Score for RCKT is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
- RCKT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
61
Alnylam Pharmaceuticals (ALNY)
is a Buy
Is Alnylam Pharmaceuticals a Buy, Sell or Hold?
- The current Alnylam Pharmaceuticals [ALNY] share price is $243.32. The Score for ALNY is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
- ALNY is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
RCKT Stock Price Chart
What is Rocket Pharmaceuticals's stock price today?
-
The Rocket Pharmaceuticals share price today is $20.66
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RCKT is experiencing slight selling pressure.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals's stock price today?
-
The Alnylam Pharmaceuticals share price today is $243.32
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALNY is experiencing slight buying pressure.
RCKT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.29 | Sell |
| Relative Strength Index (14 RSI): | 41.06 | Sell |
| Chaikin Money Flow: | -473733 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (21.01 - 22.95) | Sell |
| Bollinger Bands (100): | (21.98 - 27.8) | Sell |
ALNY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 24.3 | Buy |
| Relative Strength Index (14 RSI): | 86.74 | Buy |
| Chaikin Money Flow: | 174062 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (137.09 - 211.95) | Buy |
| Bollinger Bands (100): | (135.42 - 179.08) | Buy |
RCKT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 22.02 | Sell |
| 20-day SMA: | 22.19 | Sell |
| 50-day SMA: | 22.42 | Sell |
| 200-day SMA: | 24.26 | Sell |
| 8-day EMA: | 21.71 | Sell |
| 20-day EMA: | 22.02 | Sell |
| 50-day EMA: | 22.78 | Sell |
| 200-day EMA: | 23.52 | Sell |
ALNY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 220.62 | Buy |
| 20-day SMA: | 180.99 | Buy |
| 50-day SMA: | 161.59 | Buy |
| 200-day SMA: | 166.12 | Buy |
| 8-day EMA: | 223.64 | Buy |
| 20-day EMA: | 193.95 | Buy |
| 50-day EMA: | 171.81 | Buy |
| 200-day EMA: | 168.84 | Buy |
Rocket Pharmaceuticals Earnings Growth & RCKT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.05 per share, an increase next quarter of $0.00 per share, an increase this year of $0.22 per share, and an increase next year of $0.50 per share.
Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.32 per share, a decrease next quarter of $0.12 per share, a decrease this year of $0.46 per share, and an increase next year of $1.83 per share.
Rocket Pharmaceuticals Technical Analysis
| Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Alnylam Pharmaceuticals Technical Analysis
| Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||